1216 Federal Register / Vol. 78, No. 5 / Tuesday, January 8, 2013 / Notices 

Dated: December 21, 2012. 

Bahar Niakan, 

Director, Division of Policy and Information 

Coordination. 

[FR Doc. 2013–00031 Filed 1–7–13; 8:45 am] 

BILLING CODE 4165–15–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

Center for Scientific Review; Notice of 

Closed Meetings 

Pursuant to section 10(d) of the 

Federal Advisory Committee Act, as 

amended (5 U.S.C. App.), notice is 

hereby given of the following meetings. 

The meetings will be closed to the 

public in accordance with the 

provisions set forth in sections 

552b(c)(4) and 552b(c)(6), Title 5 U.S.C., 

as amended. The grant applications and 

the discussions could disclose 

confidential trade secrets or commercial 

property such as patentable material, 

and personal information concerning 

individuals associated with the grant 

applications, the disclosure of which 

would constitute a clearly unwarranted 

invasion of personal privacy. 

Name of Committee: Emerging 

Technologies and Training Neurosciences 

Integrated Review Group Bioengineering of 

Neuroscience, Vision and Low Vision 

Technologies Study Section. 

Date: February 7, 2013. 

Time: 8:00 a.m. to 6:00 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: Westin St. Francis Hotel, 335 Powell 

Street, San Francisco, CA 94102. 

Contact Person: Robert C Elliott, Ph.D., 

Scientific Review Officer, Center for 

Scientific Review, National Institutes of 

Health, 6701 Rockledge Drive, Room 5190, 

MSC 7846, Bethesda, MD 20892, 301–435– 

3009, elliotro@csr.nih.gov. 

Name of Committee: Surgical Sciences, 

Biomedical Imaging and Bioengineering 

Integrated Review Group, Biomedical 

Imaging Technology A Study Section. 

Date: February 7–8, 2013. 

Time: 8:00 a.m. to 5:00 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: Serrano Hotel, 405 Taylor Street, 

San Francisco, CA 94102. 

Contact Person: Behrouz Shabestari, Ph.D., 

Scientific Review Officer, Center for 

Scientific Review, National Institutes of 

Health, 6701 Rockledge Drive, Room 5126, 

MSC 7854, Bethesda, MD 20892, (301) 435– 

2409, shabestb@csr.nih.gov. 

Name of Committee: Endocrinology, 

Metabolism, Nutrition and Reproductive 

Sciences Integrated Review Group, Cellular 

Aspects of Diabetes and Obesity Study 

Section. 

Date: February 7, 2013. 

Time: 8:00 a.m. to 6:00 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: Hyatt Regency Bethesda, One 

Bethesda Metro Center, 7400 Wisconsin 

Avenue, Bethesda, MD 20814. 

Contact Person: Robert Garofalo, Ph.D., 

Scientific Review Officer, Center for 

Scientific Review, National Institute of 

Health, 6701 Rockledge Drive, Room 6156, 

MSC 7892, Bethesda, MD 20892, 301–435– 

1043, garofalors@csr.nih.gov. 

Name of Committee: Emerging 

Technologies and Training Neurosciences 

Integrated Review Group Neuroscience and 

Ophthalmic Imaging Technologies Study 

Section. 

Date: February 7, 2013. 

Time: 8:00 a.m. to 6:00 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: Renaissance Washington DC, 

Dupont Circle, 1143 New Hampshire Avenue 

NW., Washington, DC 20037. 

Contact Person: Yvonne Bennett, Ph.D., 

Scientific Review Officer, Center for 

Scientific Review, National Institutes of 

Health, 6701 Rockledge Drive, Room 5199, 

MSC 7846, Bethesda, MD 20892, 301–379– 

3793, bennetty@csr.nih.gov. 

Name of Committee: Oncology 2— 

Translational Clinical Integrated Review 

Group Chemo/Dietary Prevention Study 

Section. 

Date: February 7–8, 2013. 

Time: 8:00 a.m. to 5:00 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: Sheraton Silver Spring, 8777 

Georgia Avenue, Silver Spring, MD 20910. 

Contact Person: Sally A Mulhern, Ph.D., 

Scientific Review Officer, Center for 

Scientific Review, National Institutes of 

Health, 6701 Rockledge Drive, Room 6198, 

MSC 7804, Bethesda, MD 20892, (301) 408– 

9724, mulherns@csr.nih.gov. 

Name of Committee: Interdisciplinary 

Molecular Sciences and Training Integrated 

Review Group Enabling Bioanalytical and 

Imaging Technologies Study Section. 

Date: February 7–8, 2013. 

Time: 8:00 a.m. to 6:00 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: Renaissance Mayflower Hotel, 1127 

Connecticut Avenue NW., Washington, DC 

20036. 

Contact Person: Dennis Hlasta, Ph.D., 

Scientific Review Officer, Center for 

Scientific Review, National Institutes of 

Health, 6701 Rockledge Drive, Room 6185, 

MSC, Bethesda, MD 20892, 301–435–1047, 

dennis.hlasta@nih.gov. 

Name of Committee: Endocrinology, 

Metabolism, Nutrition and Reproductive 

Sciences Integrated Review Group, Clinical 

and Integrative Diabetes and Obesity Study 

Section. 

Date: February 7, 2013. 

Time: 8:00 a.m. to 6:00 p.m. 

Agenda: To review and evaluate grant 

applications 

Place: Residence Inn Bethesda, 7335 

Wisconsin Avenue, Bethesda, MD 20814. 

Contact Person: Nancy Sheard, SCD, 

Scientific Review Officer, Center for 

Scientific Review, National Institutes of 

Health, 6701 Rockledge Drive, Room 6046–E, 

MSC 7892, Bethesda, MD 20892, 301–408– 

9901, sheardn@csr.nih.gov. 

(Catalogue of Federal Domestic Assistance 

Program Nos. 93.306, Comparative Medicine; 

93.333, Clinical Research, 93.306, 93.333, 

93.337, 93.393–93.396, 93.837–93.844, 

93.846–93.878, 93.892, 93.893, National 

Institutes of Health, HHS) 

Dated: January 2, 2013. 

Anna Snouffer, 

Deputy Director, Office of Federal Advisory 

Committee Policy. 

[FR Doc. 2013–00088 Filed 1–7–13; 8:45 am] 

BILLING CODE 4140–01–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

Office of the Director, National 

Institutes of Health; Notice of Meeting 

Pursuant to section 10(a) of the 

Federal Advisory Committee Act, as 

amended (5 U.S.C. App.), notice is 

hereby given of a meeting of the 

Recombinant DNA Advisory Committee. 

The meeting will be open to the 

public, with attendance limited to space 

available. Individuals who plan to 

attend and need special assistance, such 

as sign language interpretation or other 

reasonable accommodations, should 

notify the Contact Person listed below 

in advance of the meeting. 

Name of Committee: Recombinant DNA 

Advisory Committee. 

Date: January 24, 2013. 

Time: 9:00 a.m. to 4:00 p.m. 

Agenda: The NIH Recombinant DNA 

Advisory Committee (RAC) will discuss 

Biosafety measures for research with highly 

pathogenic avian influenza H5N1 strains that 

have the potential to be transmissible 

through respiratory droplets and related data 

management activities. Please check the 

meeting agenda at OBA Meetings Page 

(available at the following URL: http:// 

oba.od.nih.gov/rdna_rac/rac_meetings.html) 

for more information. 

Place: National Institutes of Health, 

Building 45, Lower Level, Conference Room 

C1–C2, 45 Center Drive, Rockville, MD 

20892. 

Contact Person: Chezelle George, Office of 

Biotechnology Activities, Office of Science 

Policy/OD, National Institutes of Health, 

6705 Rockledge Drive, Room 750, Bethesda, 

MD 20892, 301–496–9838, 

georgec@od.nih.gov. 

Information is also available on the 

Institute’s/Center’s home page: http:// 

oba.od.nih.gov/rdna/rdna.html, where an 

agenda and any additional information for 

the meeting will be posted when available. 

OMB’s ‘‘Mandatory Information 

Requirements for Federal Assistance Program 

Announcements’’ (45 FR 39592, June 11, 


srobinson on DSK4SPTVN1PROD with